A Greenberg Traurig team of attorneys in Tel Aviv, Fort Lauderdale, Miami, Boston, and New York recently represented BioTelemetry Inc., a publicly traded company based in Pennsylvania, in its $280 million purchase of Switzerland’s LifeWatch AG, a health care technology company.

LifeWatch AG began its way as an Israeli entity in the 1990s and became a public Swiss company in 2001. As such, some of the company’s shareholders resided in Israel. To read more about the deal, click here to read the full article in Daily Business Review (subscription only).